Kongsberg Gruppen ASA (0F08)
London Stock Exchange · UK · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 308.20 |
|---|---|
| 52-week range | 228.90 – 426.70 |
| Return, 1 month / 3 months | −2.7% / +6.0% |
| Return, 1 year / 3 years | +5.2% / +227.3% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 53.4% |
| Worst drawdown (1 year) | -34.7% |
| Average daily value traded | 21.07M NOK |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kongsberg Gruppen is a Norwegian industrial group based in Kongsberg that serves defence and maritime customers. It develops and supplies defence products such as missiles, remote weapon stations and command systems, and it provides maritime and offshore equipment including automation, dynamic positioning and propulsion control for ships and rigs. Its customers are armed forces, shipowners, shipyards and energy companies around the world, and the group also works in areas such as space and surveillance technology.
Kongsberg Gruppen ASA trades under the code 0F08 on the London Stock Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kongsberg Gruppen ASA (0F08) trades on the London Stock Exchange in UK. It last closed at NOK 308.20 on 27 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 2,352 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.2% and over the last three months it rose 6.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.4% | ||
| From 52-week high | -26.6% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.0% | ||
| 6-month return | -0.1% | ||
| 12-month return, skipping the last month | 8.1% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.7% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 21.07M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | −2.7% |
| 3 months | +6.0% |
| 6 months | −0.1% |
| 1 year | +5.2% |
| 3 years | +227.3% |
| 5 years | +514.1% |
Signals
| 50-day / 200-day average | 309.67 / 329.37 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Apr 2026 | NOK 2.8930 |
| 9 Oct 2025 | NOK 1.9837 |
| 8 May 2025 | NOK 8.2656 |
| 9 Oct 2024 | NOK 5.7859 |
| 8 May 2024 | NOK 5.7859 |
| 12 May 2023 | NOK 6.9431 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.